STAAR Surgical Company today reported that the U.S. Food and Drug Administration (FDA) has approved the Company’s Myopic VISIAN ICL for use in the correction of myopia in adults.
More: continued here
You can respond, or trackback from your own site.
Name (required)
Mail (will not be published) (required)
Website